BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19276234)

  • 1. A combined dexamethasone desmopressin test as an early marker of postsurgical recurrence in Cushing's disease.
    Castinetti F; Martinie M; Morange I; Dufour H; Sturm N; Passagia JG; Conte-Devolx B; Chabre O; Brue T
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1897-903. PubMed ID: 19276234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative follow-up of Cushing's disease using cortisol, desmopressin and coupled dexamethasone-desmopressin tests: a head-to-head comparison.
    Le Marc'hadour P; Muller M; Albarel F; Coulon AL; Morange I; Martinie M; Gay E; Graillon T; Dufour H; Conte-Devolx B; Chabre O; Brue T; Castinetti F
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):216-22. PubMed ID: 25660243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing's disease.
    Romanholi DJ; Machado MC; Pereira CC; Danilovic DS; Pereira MA; Cescato VA; Cunha Neto MB; Musolino NR; de Mendonça BB; Salgado LR
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):117-22. PubMed ID: 18182093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of Cushing's disease preceded by the reappearance of ACTH and cortisol responses to desmopressin test.
    Dall'Asta C; Barbetta L; Bonavina L; Beck-Peccoz P; Ambrosi B
    Pituitary; 2004; 7(3):183-188. PubMed ID: 16328567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Desmopressin Test Predicts Better Than Basal Cortisol the Long-Term Surgical Outcome of Cushing's Disease.
    Vassiliadi DA; Balomenaki M; Asimakopoulou A; Botoula E; Tzanela M; Tsagarakis S
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4878-4885. PubMed ID: 27662440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing's disease.
    Losa M; Bianchi R; Barzaghi R; Giovanelli M; Mortini P
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3322-8. PubMed ID: 19584185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.
    Hameed N; Yedinak CG; Brzana J; Gultekin SH; Coppa ND; Dogan A; Delashaw JB; Fleseriu M
    Pituitary; 2013 Dec; 16(4):452-8. PubMed ID: 23242860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Cushing's disease remission after transsphenoidal surgery based on early serum cortisol dynamics.
    Costenaro F; Rodrigues TC; Rollin GA; Ferreira NP; Czepielewski MA
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):411-8. PubMed ID: 23895112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of the combined corticotropin-releasing hormone plus desmopressin stimulation during petrosal sinus sampling is both sensitive and specific in differentiating patients with Cushing's disease from patients with the occult ectopic adrenocorticotropin syndrome.
    Tsagarakis S; Vassiliadi D; Kaskarelis IS; Komninos J; Souvatzoglou E; Thalassinos N
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2080-6. PubMed ID: 17356045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease.
    Tirabassi G; Faloia E; Papa R; Furlani G; Boscaro M; Arnaldi G
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1115-22. PubMed ID: 20080839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging.
    Testa RM; Albiger N; Occhi G; Sanguin F; Scanarini M; Berlucchi S; Gardiman MP; Carollo C; Mantero F; Scaroni C
    Eur J Endocrinol; 2007 Feb; 156(2):241-8. PubMed ID: 17287414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
    Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
    Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease.
    Amlashi FG; Swearingen B; Faje AT; Nachtigall LB; Miller KK; Klibanski A; Biller BM; Tritos NA
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3770-7. PubMed ID: 26196950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmopressin test in the diagnosis and follow-up of cyclical Cushing's disease.
    Leal-Cerro A; Martín-Rodríguez JF; Ibáñez-Costa A; Madrazo-Atutxa A; Venegas-Moreno E; León-Justel A; García-Hernández N; Luque RM; Castaño JP; Cano DA; Soto-Moreno A
    Endocrinol Nutr; 2014 Feb; 61(2):69-76. PubMed ID: 24183946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild cushing's disease from pseudo-Cushing's syndrome.
    Gatta B; Chabre O; Cortet C; Martinie M; Corcuff JB; Roger P; Tabarin A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4290-3. PubMed ID: 17635947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The desmopressin test in the diagnosis of Cushing's disease].
    Gasińiska T; Dec R; Wichary H; Pietrasik L; Kulawik G
    Pol Arch Med Wewn; 2007; 117(1-2):20-6. PubMed ID: 17642202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotrophin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and pseudo-Cushing state: a comparative study.
    Tirabassi G; Papa R; Faloia E; Boscaro M; Arnaldi G
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):666-72. PubMed ID: 21554373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.